Michele Korfin

Chief Operating & Commercial Officer at Gamida Cell Ltd.

Michele Korfin

Michele Korfin

Chief Operating & Commercial Officer at Gamida Cell Ltd.

Overview
Career Highlights

Gamida Cell Ltd.
Tyme Technologies, Inc.

RelSci Relationships

1065

Number of Boards

1

Birthday

1972

Age

49

Contact Data
Trying to get in touch with Michele Korfin? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Michele Korfin likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Commercial Officer at Pharmacyclics LLC

Relationship likelihood: Strong

Director at BioNJ, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at BioNJ, Inc.

Relationship likelihood: Strong

Treasurer & Director at BioNJ, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Gamida Cell Ltd.

Relationship likelihood: Strong

Chief Financial Officer at Crazy Labs Ltd.

Relationship likelihood: Strong

Faculty Affiliate, Department of Medical Ethics at New York University - School of Medicine

Relationship likelihood: Strong

Director of MIS at BioNJ, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Clal Biotechnology Industries Ltd.

Relationship likelihood: Strong

Former Director & Chief Executive Officer at Gamida Cell Ltd.

Relationship likelihood: Strong

Paths to Michele Korfin
Potential Connections via
Relationship Science
You
Michele Korfin
Chief Operating & Commercial Officer at Gamida Cell Ltd.
Education

Rutgers, The State University of New Jersey, is a leading national research university and the state’s preeminent, comprehensive public institution of higher education. Rutgers is dedicated to teaching that meets the highest standards of excellence; to conducting research that breaks new ground; and to providing services, solutions, and clinical care that help individuals and the local, national, and global communities where they live. Founded in 1766, Rutgers teaches across the full educational spectrum: preschool to precollege; undergraduate to graduate; postdoctoral fellowships to residencies; and continuing education for professional and personal advancement.

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

Career History
Chief Operating Officer
Prior - 2020

Tyme Technologies, Inc. is a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ.

Head-Oncology Sales Force
2004 - 2016

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies

Vice President-Market Access
2016 - 2018

Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam in June 2009 and is headquartered in Santa Monica, CA.

Boards & Committees
Secretary & Director
Current

BioNJ, Inc. is an American private company located in Trenton, NJ. The firm promotes the biotechnology industry in New Jersey. It was founded in 1994 by Abraham Abuchowski, James J. Marino and Jayne C. Gershkowitz. Debbie Hart is currently the CEO of the company.The company says this about itself: BioNJ is the life sciences trade association in New Jersey with nearly 400 Member companies representing research-based life sciences organizations and stakeholders across the ecosystem from the largest biopharmaceutical companies to early stage start-ups. BioNJ is dedicated to ensuring a vibrant ecosystem where Science is Supported, Companies are Created, Drugs are Developed and Patients are Paramount. Because Patients Can't Wait®, BioNJ supports its Members in the discovery, development and commercialization of therapies and cures that save and improve lives and lessen the burden of illness and disease to society by driving capital formation, fostering entrepreneurship, advocating for public policies that advance medical innovation, providing access to talent and education and offering a cost-saving array of critical commercial resources.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$100 - $249
2015

GIRL SCOUTS OF NORTHERN NEW JERSEY BUILDS GIRLS OF COURAGE, CONFIDENCE, AND CHARACTER WHO MAKE THE WORLD A BETTER PLACE.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Michele Korfin. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Michele Korfin's profile does not indicate a business or promotional relationship of any kind between RelSci and Michele Korfin.